Sarepta Therapeutics, Inc. (SRPT)
23.02
-0.21
(-0.90%)
USD |
NASDAQ |
Apr 06, 14:35
Sarepta Therapeutics SG&A Expense (TTM) : 491.72M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Keros Therapeutics, Inc. | 46.85M |
| Merck & Co., Inc. | 10.73B |
| PTC Therapeutics, Inc. | 347.14M |
| Gilead Sciences, Inc. | 8.398B |
| REGENXBIO, Inc. | 82.86M |